Joseph Bogdan, MD
Adult Reconstructive Orthopaedic Surgery · Brick, NJNPI 1730161084
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Johnson & Johnson at 28.4% of the total. 2024 is the largest year on record at $160, 3.2 times the $50 reported in 2019. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in NJ, where the typical reported total is $8,051.
Across 23 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$118
- Heraeus Medical, LLC.$69
- Bioventus LLC$60
- Baxter Healthcare$41
- Pfizer$27
- Davol Inc.$21
- plus $79 from 5 others
What the payments were for
- Food & beverage$417100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $118 |
| Heraeus Medical, LLC. | 6 | $69 |
| Bioventus LLC | 2 | $60 |
| Baxter Healthcare | 1 | $41 |
| Pfizer | 2 | $27 |
| Davol Inc. | 1 | $21 |
| Linvatec Corporation | 1 | $19 |
| Si-bone, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $15 |
| Next Science LLC | 1 | $13 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
How this compares
$417 in reported general payments places this provider in the 10th percentile of 39 adult reconstructive orthopaedic surgery providers in New Jersey.
See all adult reconstructive orthopaedic surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 107 | $1,397 |
| Methylprednisolone | 196 | $1,229 |
| Meloxicam | 136 | $436 |
| Amoxicillin | 117 | $292 |
| Mupirocin | 49 | $265 |
| Clindamycin Hcl | 22 | $86 |
| Cyclobenzaprine Hcl | 19 | $51 |
| Montelukast Sodium | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Brick
- David RodricksBrick$7K
- Atul KamathManasquan$4M
- Alfred TriaSomerset$582K
- John DundonHackettstown$573K
- Ismar DizdarevicRidgewood$368K
- David FeldmanEnglewood$335K
- Mark PizzurroRidgewood$239K
- Jeffrey LearyNew Providence$148K
- Timothy HendersonWayne$140K
- Anthony CostaEatontown$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.